Eli Lilly is advancing its Phase 2 clinical trial to test LY3841136 for weight management in obese and overweight adults.

Highview Capital Management increased its Alphabet holdings by 9.2% in Q1, acquiring 2,672 additional shares, now worth $4.9 ...